Relevant factors for neurologists to define effectiveness of migraine preventive drugs and take decisions on treatment. My-LIFE European Delphi survey.
Patricia Pozo-RosichRaquel Gil-GouveiaAnne DonnetAnne-Christine PooleAstrid GendollaShazia K AfridiRainel Sanchez-De la RosaGisela M TerwindtCristina TassorelliPublished in: European journal of pain (London, England) (2021)
In clinical practice, criteria to define the effectiveness of migraine preventive treatment and factors that guide treatment stop or continuation are not clearly defined. In this simulated clinical setting study, a reduction in the use of acute migraine medications was the factor associated with preventive treatment effectiveness definition. This study also revealed that factors strongly associated with the decision of treatment continuation in real life are the acute migraine medications use and a positive patient's perception of treatment effectiveness.